COPD Scoring Systems in ICU (crosssectional)

Role of Disease - Severity Scoring Systems in Predicting Out Come Among COPD Patients Admitted at Assiut University Hospital

The aim of our study was to assess the performance of APACHE II and SAPS II scoring methods in predicting out come among critically ill COPD patients admitted to the respiratory intensive care unit (RICU) at Assiut University Hospital

Study Overview

• Status: Not yet recruiting
• Conditions: COPD Scoring System
• Intervention / Treatment: Other: COPD scoring ststems in ICU

Detailed Description

Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating airway disease that results in a large burden, both medically and financially. It affects millions of people around the world and causes great rates of morbidity and mortality. This burden is anticipated to increase with an estimated 5.8 million deaths annually by 2030 [1].

A large proportion of patients with COPD usually require admission to the ICU and it may be helpful to recognize patients at the time of admission who are probable to have bad consequence, so that these patients can be managed violently [2 There are many ICU scoring models, and numerous new systems are being progressed to assess severity of illness in ICU patients. The use of scoring models particularly developed for patient evaluation at the time of ICU entry has decreased many troubles and helped therapy delineation.

Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) scoring systems are the two models that are greatly used by the majority of ICUs to forecast the clinical consequence [3

• Study Type: Observational
• Enrollment (Anticipated): 195

Contacts and Locations

• Study Contact: Name: Ebtesam Mohamed thabet, 1; Phone Number: 01020135853; Email: ebtesamm582@gmail.com
• Study Contact Backup: Name: Amany Omar Mohamed, 3; Phone Number: 0111252424 9; Email: amanyomd@hotmail.com

Study Locations

• Egypt
  • Assiut, Egypt
    • Ebtesam

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 95 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Role of disease - severity scoring systems in predicting out come among COPD patients admitted at Assiut University Hospital

Description

Inclusion Criteria All patients involved have undergone full history with special stress on age, gender, special habits, and associated diseases. Information such as the patient's need for mechanical ventilation as well as the duration of lodging in the ICU was entered. Routine laboratory variables were also registered. Patients were followed up until their outcome was determined. The outcome was decided according to the mortality within the ICU and recorded as survivors and nonsurvivors. Scores of

APACHE II and SAPS II were calculated:

-

Exclusion Criteria:

• Excluded from this study were COPD patients admitted to the ICU because of any other underlying problem such as those with acute cardiac situation, patients with respiratory failure due to other diseases along with COPD, patients who lasted less than 24 h in the ICU, and those who died before the completion of data collection.

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
COPD scorng systems in ICU	Role of disease - severity scoring systems in predicting out come among COPD patients admitted at Assiut University Hospital.	Baseline

Collaborators and Investigators

• Sponsor: Assiut University

Publications and helpful links

General Publications

• Retraction. J Thromb Haemost. 2021 Aug;19(8):2096. doi: 10.1111/jth.15210. Epub 2021 Jan 1.

Study record dates

Study Major Dates

• Study Start (Anticipated): August 1, 2022
• Primary Completion (Anticipated): August 1, 2023
• Study Completion (Anticipated): September 1, 2023

Study Registration Dates

• First Submitted: August 28, 2022
• First Submitted That Met QC Criteria: August 29, 2022
• First Posted (Actual): August 31, 2022

Study Record Updates

• Last Update Posted (Actual): August 31, 2022
• Last Update Submitted That Met QC Criteria: August 29, 2022
• Last Verified: August 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: C0PD scoring systems

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No